Aptamers offer several advantages over traditional antibodies in nanotechnological applications. Firstly, they are chemically synthesized, which allows for greater control over their production and modification. They are also more stable and can be easily modified with functional groups for attachment to nanomaterials. Additionally, aptamers can be selected to bind to a wide range of targets, including those that are difficult for antibodies to recognize.
